Effects of high-dose vitamin E supplementation on oxidative stress and microalbuminuria in young adult patients with childhood onset type 1 diabetes mellitus

Diabetes/Metabolism Research and Reviews

Volumn 23, Issue 7, 2007, Pages 539-546

  Giannini, C ^a   Lombardo, F ^b   Curro F ^b   Pomilio, M ^a   Bucciarelli, T ^a   Chiarelli, F ^a   Mohn, A ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Diabetec nephropathy; Growth factors; Microalbuminuria; Oxidative stress; Type1 diabetes mellitus; Vitamin E supplementation

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; HEMOGLOBIN A1C; INSULIN; LONG ACTING INSULIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PLACEBO; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BEDTIME DOSAGE; CAUCASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; MALE; MICROALBUMINURIA; MORNING DOSAGE; ONSET AGE; OXIDATIVE STRESS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; AGE OF ONSET; ALBUMINURIA; BODY MASS INDEX; CHILD; CREATININE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; OXIDATIVE STRESS; PATIENT SELECTION; PLACEBOS; VITAMIN E;

EID: 35548965117     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.717     Document Type: Article

References (50)

1. US Renal Data System, USRDS. 2005; Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD May 2006, http://www.usrds.org/atlas.htm.
2. Kurokawa K, Nangaku M, Saito A, Inagi R, Miyata T. Current issues and future perspectives of chronic renal failure. J Am Soc Nephrol 2002; 13(Suppl. 1): S3-S6.
3. American Diabetes Association (ADA). Nephropathy in diabetes. Diabetes Care 2004; 27: S79-S83.
4. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89-93.
5. Mogensen CE, Keane WF, Bennett PH, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995; 346: 1080-1084.
6. Hommel E, Mathiesen E, Edsberg B, Bahnsen M, Parving HH. Acute reduction of arterial blood pressure reduces urinary albumin excretion in type 1 (insulin-dependent) diabetic patients with incipient nephropathy. Diabetologia 1986; 29: 211-215.
7. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed) 1987; 294: 1443-1447.
8. Feener EP, King GL. Vascular dysfunction in diabetes mellitus. Lancet 1997; 350(Suppl. 1): SI9-SI13.
9. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001; 17(3): 189-212.
10. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-267.
11. Ceriello A, dello Russo P, Amstad P, Cerutti P. High glucose induces antioxidant enzymes in human endothelial cell in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes 1996; 45: 471-477.
12. Sechi LA, Ceriello A, Griffin CA, et al. Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia 1997; 40: 23-29.
13. Reddi AS, Bollineni JS. Renal cortical expression of mRNAs for antioxidant enzymes in normal and diabetic rats. Biochem Biophys Res Commun 1997; 235: 598-601.
14. Ceriello A, Quatraro A, Giugliano D. New insight on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med 1992; 9: 297-299.
15. Williamson JR, Chang K, Frangos M, et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993; 42: 801-813.
16. Wolff SP, Dean RT. Glucose autooxidation and protein modification. The potential role of "autoxidative glycosylation" in diabetes. Biochem J 1987; 245: 243-250.
17. DeRubertis FR, Craven PA. Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 1994; 43: 1-8.
18. Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development of diabetic complications. Horm Res 2000; 53(2): 53-67.
19. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-1456.
20. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-1449.
21. Regnstrom J, Nilsson J, Moldeus P, et al. Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease. Am J Clin Nutr 1996; 63(3): 377-385.
22. Koya D, Lee I-K, Ishii H, Kanoh H, King GL. Prevention of glomerular dysfunction in diabetic rats by treatment with dalphatocopherol. J Am Soc Nephrol 1997; 18: 426-435.
23. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S-E, King GL. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 1993; 265: E783-E793.
24. Ishii H, Jirousek MR, Koya D, et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC b inhibitor. Science 1996; 272: 728-731.
25. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the national high blood pressure education program. Pediatrics 1996; 98: 649-658.
26. Bursell SE, Clermont AC, Aiello LP, et al. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 1999; 22: 1245-1251.
27. Lee BL, Chua SC, Ong HY, Ong CN. High-performance liquid chromatographic method for routine determination of vitamins A and E and beta-carotene in plasma. J Chromatogr 1992; 581: 41-47.
28. Foreman JR, Karlin JB, Edelstein C, Juhn DJ, Rubenstein AH, Scanu AM. Fractionation of human serum lipoproteins by single-spin gradient ultracentrifugation: quantification of apolipoproteins B and A-1 and lipid components. J Lipid Res 1977; 18: 759-767.
29. Lowry OH, Resenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagen. J Biol Chem 1951; 193: 265-275.
30. Belcher JD, Balla J, Balla G, et al. Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler Thromb 1993; 13(12): 1779-1789.
31. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989; 6: 67-75.
32. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 1990; 86: 75-79.
33. Mezzetti A, Guglielmi MD, Pierdomenico SD, et al. Increased systemic oxidative stress after elective endarterectomy: relation to vascular healing and remodeling. Arterioscler Thromb Vasc Biol 1999; 19: 2659-2665.
34. Lenz T, Haak T, Malek J, Gröne HJ, Geiger H, Gossmann J. Vascular endothelial growth factor in diabetic nephropathy. Kidney Blood Press Res 2003; 26: 338-343.
35. Korpinen E, Teppo AM, Hukkanen L, Akerblom HK, Gronhagen-Riska C, Vaarala O. Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care 2000; 23: 664-668.
36. Messent JW, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 1992; 41: 836-839.
37. Chiarelli F, Trotta D, Verrotti A, Mohn A. Kidney involvement and disease in patients with diabetes. Panminerva Med 2003; 45: 23-41.
38. Chiarelli F, Cipollone F, Mohn A, et al. Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes. Diabetes Care 2002; 25: 1829-1834.
39. Engelen W, Keenoy BM, Vertommen J, De Leeuw I. Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes. Am J Clin Nutr 2000; 72: 1142-1149.
40. Jain SK, McVie R, Smith T. Vitamin E supplementation restores glutathione and malonildialdehyde to normal concentrations in erythrocytes of type 1 diabetic children. Diabetes Care 2000; 23: 1389-1394.
41. Astley S, Langrish-Smith A, Southon S, Sampson M. Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes. Diabetes Care 1999; 22: 1626-1631.
42. Pinkney JH, Downs L, Hopton M, Mackness MI, Bolton CH. Endothelial dysfunction in Type 1 diabetes mellitus: relationship with LDL oxidation and the effects of vitamin E. Diabet Med 1999; 16: 993-999.
43. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. Arterioscler Thromb 1993; 13: 590-600.
44. Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H. Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 1991; 32: 1325-1332.
45. Santilli F, Spagnoli A, Mohn A, et al. Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria. J Clin Endocrinol Metab 2001; 86: 3871-3876.
46. Keegan A, Walbank H, Cotter MA, Cameron NE. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia 1995; 38: 1475-1478.
47. Skyrme-Jones RA, O'Brien RC, Berry KL, Meredith IT. Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. J Am Coll Cardiol 2000; 36: 94-102.
48. Skyrme-Jones RA, Meredith IT. Soluble adhesion molecules, endothelial function and vitamin E in type 1 diabetes. Coron Artery Dis 2001; 12: 69-75.
49. Molitch ME, Steffes MW, Cleary PA, Nathan DM. Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Kidney Int 1993; 43: 668-674.
50. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986.